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Summary
Recent results suggest that long-lasting potentiation
at hippocampal synapses involves the rapid forma-
tion of clusters or puncta of presynaptic as well as
postsynaptic proteins, both of which are blocked by
antagonists of NMDA receptors and an inhibitor of ac-
tin polymerization. We have investigated whether the
increase in puncta involves retrograde signaling
through the NO-cGMP-cGK pathway and also exam-
ined the possible roles of two classes of molecules
that regulate the actin cytoskeleton: Ena/VASP pro-
teins and Rho GTPases. Our results suggest that NO,
cGMP, cGK, actin, and Rho GTPases including RhoA
play important roles in the potentiation and act di-
rectly in both the presynaptic and postsynaptic neu-
rons, where they contribute to the increase in puncta
of synaptic proteins. cGK phosphorylates synaptic
VASP during the potentiation, whereas Rho GTPases
act both in parallel and upstream of cGMP, in part by
maintaining the synaptic localization of soluble gua-
nylyl cyclase.
Introduction
Recent studies have provided support for postsynaptic
mechanisms of hippocampal long-term potentiation
(LTP), including changes in the surface expression of
AMPA glutamate receptors in clusters or “puncta” that
label for the GluR1 subunit (Malinow and Malenka,
2002). To investigate whether analogous changes also
occur presynaptically, Antonova et al. (2001) examined
immunoreactivity for pre- as well as postsynaptic pro-
teins during glutamate-induced potentiation in dissoci-
ated cultures of hippocampal neurons. This form of po-
tentiation is dependent on activation of postsynaptic*Correspondence: rdh1@columbia.eduNMDA receptors like LTP in slices or in vivo (Malgaroli
and Tsien, 1992; Antonova et al., 2001) and is advanta-
geous for imaging studies. Consistent with other
studies, Antonova et al. (2001) found that there is an
increase in GluR1 puncta at the onset of the potentia-
tion. However, they also found that these postsynaptic
changes are accompanied by a rapid increase in clus-
ters of the presynaptic proteins synaptophysin and sy-
napsin I and sites where the pre- and postsynaptic pro-
teins colocalize and therefore might participate in the
formation and/or maturation of functional synapses.
Imaging of synaptophysin-GFP in living neurons showed
that the new presynaptic synaptophysin puncta arise
from clustering of preexisting protein, as is thought to
occur for postsynaptic GluR1 puncta.
These results supported an emerging view that even
the early stages of long-lasting plasticity involve micro-
structural changes (Engert and Bonhoeffer, 1999; Ma-
letic-Savatic et al., 1999) and showed that those
changes can occur presynaptically as well as postsyn-
aptically. In turn, however, they raised a new set of
questions about the mechanisms of the pre- and post-
synaptic changes and how they are coordinated. The
increase in synaptophysin puncta is clearly a presynap-
tic event, but it is blocked by antagonists of NMDA re-
ceptors that are presumably postsynaptic, implying
some sort of retrograde signaling. A variety of evidence
suggests that nitric oxide (NO), a freely diffusible mole-
cule that is produced in response to NMDA receptor
activation, may play such a role (reviewed in Hawkins
et al., 1998). NO contributes to long-lasting potentiation
in hippocampal cultures by activating presynaptic gua-
nylyl cyclase and cGMP-dependent protein kinase
(cGK) (O’Dell et al., 1991; Arancio et al., 1995, 1996,
2001). We have therefore investigated whether the NO-
cGMP-cGK pathway also contributes to the increase in
synaptophysin puncta during glutamate-induced po-
tentiation in culture.
Antonova et al. (2001) found that the increases in
synaptophysin and GluR1 puncta during potentiation
are also blocked by an inhibitor of actin polymerization.
We therefore investigated the roles of actin and two
classes of molecules that regulate the actin cytoskele-
ton and that can in turn be regulated by cGK: Ena/VASP
proteins and Rho GTPases. The Ena/VASP family of
proteins includes Drosophila enabled (Ena), mammalian
Ena (Mena), vasodilator-stimulated phosphoprotein
(VASP), and Ena/VASP-like protein (Evl). These proteins
are associated with adherins junctions and highly dy-
namic membrane regions, where they regulate actin
polymerization and actin filament branching and turn-
over (Reinhard et al., 2001; Kwiatkowski et al., 2003).
VASP has been studied more extensively in nonneural
tissue, including platelets and epithelial cells, whereas
Mena is more prominent in neurons. However, VASP is
also present in neurons and is detectable by Western
blot in dissociated cultures of hippocampal neurons,
where it can be phosphorylated in response to cGMP
analogs (Arancio et al., 2001).
Rho GTPases are a family of small GTP binding pro-
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390teins that are involved in regulation of the actin cy-
toskeleton for a variety of purposes in many cell types
(Etienne-Manneville and Hall, 2002). The three best-studied
members of the family are RhoA, Rac, and Cdc42, each
of which tends to produce different types of morpho-
logical changes in neurons (Luo, 2002). RhoA is a com-
ponent of adhesion complexes, where it can be regulated
by extracellular signals and in turn regulates stress fiber
contraction via Rho kinase (ROCK), which produces
enhanced phosphorylation of myosin light chain (Petit
and Thiery, 2000; Fukata et al., 2001). The NO-cGMP-
cGK pathway mediates smooth muscle relaxation in
part through effects on this pathway (Sauzeau et al.,
2000; Pfitzer, 2001). RhoA also stimulates actin poly-
merization via both the ROCK-LIM kinase-cofilin path-
way and the mDia-profilin pathway, which act coopera-
tively with each other (Geneste et al., 2002) and with
VASP, perhaps due to an interaction of VASP with mDia
or profilin (Grosse et al., 2003). cGKI can regulate this
pathway at the levels of both RhoA and VASP in other
systems (Gudi et al., 2002; Zhuang et al., 2004).
Results
Long-Lasting Potentiation and the Increases
in Synaptophysin and GluR1 Puncta
Involve NO, cGMP, and cGK
Brief application of glutamate (200 M in Mg2+-free sa-
line for w1 min) produced a rapid and long-lasting
increase in the frequency of spontaneous miniature ex-
citatory postsynaptic currents (mEPSCs) compared to
saline control (F[1,60] = 19.25, p < 0.001) (Figure 1).
There was no significant change in mEPSC amplitude
in these experiments (average 0–30 min post-gluta-
mate = 103% ± 5% of baseline for glutamate and 94% ±
5% for control). The NO synthase inhibitor Nϖ-nitro-L-
arginine (NOArg, 100 M for l hr) or the cGK inhibitor
Rp-8-Br-cGMPS (100 M for 1 hr) blocked the increase
in mEPSC frequency (F = 18.30, p < 0.001 for NOArg,
and F = 14.94, p < 0.001 for Rp-8-Br-cGMPS) but had
no significant effects on baseline frequency. Neither the
membrane-permeable cGMP analog 8-Br-cGMP (500
uM for 5 min, data not shown) nor the more potent ana-
F
N
(log 8-pCPT-cGMP (50 uM for 10 min) had significant
m
effects on mEPSC frequency, but 8-pCPT-cGMP “res- n
cued” glutamate-induced potentiation in the presence (
cof Nϖ-nitro-L-arginine (F = 12.67, p < 0.001). These
mresults suggest that the NO-cGMP-cGK pathway is in-
avolved in the long-lasting potentiation of mEPSC fre-
(quency by glutamate and that cGMP acts synergisti-
c
cally with some other effect of glutamate, such as N
spike activity. w
bWe used recombinant adenovirus to express a syn-
taptophysin-GFP (green fluorescent protein) fusion pro-
dtein, which was distributed in clusters or puncta in the
rneurons (Figure 2). The puncta were continually gained
t
and lost under control conditions (saline application), (
so that the total number of puncta remained relatively m
mconstant. Brief application of glutamate produced a net
8increase in the number of puncta that was due to an
Rincrease in the number gained, occurred rapidly, and
mwas maintained for more than 30 min (p < 0.01 at 1, 10,
d
and 30 min). The increase was blocked by either Nϖ-igure 1. Long-Lasting Potentiation of mEPSC Frequency Involves
O, cGMP, and cGK
A) Examples of spontaneous mEPSCs before (Pre) and 5 and 30
in after brief application of glutamate to cultured hippocampal
eurons.
B) The average change in mEPSC frequency following brief appli-
ation of glutamate or saline (control), glutamate following pretreat-
ent with Nϖ-nitro-L-arginine (NOArg), or pretreatment with NOArg
lone.
C) The average change in mEPSC frequency following brief appli-
ation of 8-pCPT-cGMP and glutamate following pretreatment with
OArg, 8-pCPT-cGMP alone, glutamate following pretreatment
ith Rp-8Br-cGMPS, pretreatment with Rp-8-Br-cGMPS alone, or
rief application of 8-pCPT-cGMP and glutamate following pre-
reatment with NOArg and toxin B. There was a significant overall
ifference between the nine groups in a two-way ANOVA with one
epeated measure (F[8,60] = 7.71, p < 0.001). Data were normalized
o the average value during the 10 min before glutamate application
baseline) in each experiment. The average baseline values (in
in−1) were 75 (glutamate, n = 12), 164 (control, n = 9), 99 (gluta-
ate + NOArg, n = 9), 117 (NOArg, n = 6), 138 (glutamate + NOArg +
-pCPT-cGMP, n = 6), 143 (8-pCPT-cGMP, n = 7), 66 (glutamate +
p-8-Br-cGMPS, n = 8), 43 (Rp-8-Br-cGMPS, n = 7), and 65 (gluta-
ate + NOArg + 8-pCPT-cGMP + toxin B, n = 5), not significantly
ifferent by a one-way ANOVA.
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391Figure 2. The Increase in Synaptophysin
Puncta during Potentiation Involves NO and
cGK
(A) Examples of synaptophysin-GFP fluores-
cent puncta before (green) superimposed on
those 10 min after (red) brief application of
saline (control), glutamate, glutamate follow-
ing pretreatment with NOArg, or glutamate
following pretreatment with Rp-8-Br-cGMPS.
Puncta that were present after only appear
red, those that were present before only ap-
pear green, and those that were present at
both times appear yellow. Scale bar, 5 m.
(B) Average number of synaptophysin-GFP
puncta present 10 min after only (gained),
before only (lost), or both times (stable) in
each of the experimental groups.
(C) Average time course of changes in the
total number of synaptophysin-GFP puncta.
There was a significant overall difference be-
tween the four groups in a two-way ANOVA
(F[3,61] = 10.85, p < 0.01). In this and subse-
quent figures, **p < 0.01, *p < 0.05 com-
pared to control, #p < 0.05 compared to no inhibitor. The number of puncta in one field (94 m × 142 m) per dish has been normalized to
the number before glutamate application (baseline) in each experiment. The average baseline values per field were 90 (control, n = 21 dishes),
63 (glutamate, n = 21), 80 (glutamate + NOArg, n = 14), and 161 (glutamate + Rp-8-Br-cGMPS, n = 9).sin-IR puncta, the increase in the intensity of cGMP-IRcontrol), and this increase was maintained for more
Figure 3. The Increase in Synaptophysin Puncta Is Accompanied by a Transient, NO-Mediated Increase in cGMP
(A) Examples of synaptophysin-IR (red), cGMP-IR (green), and colocalization (yellow or orange) in dishes fixed 5 min after brief application of
saline (control) and 5 or 30 min after brief application of glutamate. Scale bar, 10 m.
(B) Average results from experiments like the ones shown in (A) (n = 11, 13, and 6 dishes). The number of puncta and the cGMP intensities
in the neurons in ten fields (94 m × 142 m) per dish have been normalized to values from comparable fields in control dishes from the
same culture batch. The average control number of puncta per field was 75.
(C) Examples of synaptophysin-IR, cGMP-IR, and colocalization in dishes fixed 5 min after either brief application of glutamate following
pretreatment with NOArg or brief application of NO.
(D and E) Average results from experiments like the ones shown in (C) (n = 5, 6, and 5 in [D] and 4 and 8 in [E]). The average control numbers
of puncta were 54 and 13.nitro-L-arginine or Rp-8-Br-cGMPS (p < 0.01 at each
time for either inhibitor), suggesting that NO and cGK
are involved.
Brief application of glutamate also produced an
increase in the number of synaptophysin-IR (immunore-
active) puncta when the tissue was fixed 5 min after
glutamate (t[21] = 3.13, p < 0.01 compared to salinethan 30 min (t[9] = 2.98, p < 0.05) (Figure 3). There was
no significant change in the size (100% ± 8%) or inten-
sity (97% ± 6%) of the synaptophysin-IR puncta. Gluta-
mate also produced an increase in the intensity of
cGMP-IR throughout the neuron, including the sites of
synaptophysin-IR puncta (t[22] = 3.67, p < 0.01). How-
ever, unlike the increase in the number of synaptophy-
Neuron
392Figure 4. The Increase in GluR1 as well as
Synaptophysin Puncta Involves cGMP and
cGK
(A) Examples of synaptophysin-IR (red),
GluR1-IR (green), and colocalization (either
yellow or adjacent red and green) in dishes
fixed 5 min after brief application of saline
(control), glutamate, glutamate following pre-
treatment with Rp-8-Br-cGMPS, or 8-Br-
cGMP. Scale bar, 5 m.
(B and C) Average results from experiments
like the ones shown in (A) (n = 9 dishes in
each group in [B] and 18 in [C]). The average
control values per field were 62 (syp), 61
(GluR1), and 20 (colocalized) in (B) and 57,
65, and 19 in (C).2002). The relatively low colocalization might also re- increase in synaptophysin puncta.
Figure 5. cGKI and an Endogenous Sub-
strate, VASP, Are Synaptically Localized
(A) Examples of colocalization of synapto-
physin-IR and cGKI-IR, synaptophysin-IR
and VASP-IR, P-VASP-IR and sGC-IR, and
P-VASP-IR and cGKI-IR. Scale bar, 5 m.
(B) Average number of sites where puncta of
two different types colocalized under control
conditions as a percent of the number of
the first.
(C) Average number of sites where puncta of
two different types were adjacent (within
1 m) but did not overlap as a percent of the
number of sites where they colocalized (n =
6, 21, 6, 12, 6, 6, 18, 6, 3, and 3 dishes). Data
for synaptophysin (Syp) and synapsin I (Syn)
and those for synaptophysin and NR1 are
from Antonova et al. (2001).
The error bars in this figure show the SDs to
indicate the range of values.was not maintained 30 min after glutamate, consistent f
lwith the idea that a transient increase in cGMP acti-
vates a signaling pathway that triggers a longer-lasting C
nchange in synaptophysin. The increases in synaptophy-
sin-IR puncta and cGMP-IR intensity were both p
nblocked by Nϖ-nitro-L-arginine (t[8] = 3.05, p < 0.05 for
synaptophysin-IR puncta and t[9] = 10.46, p < 0.001 for o
scGMP-IR) and were mimicked by brief application of
NO (20 nM for w1 min; t[3] = 4.29, p < 0.05 for synapto- o
wphysin-IR puncta and t[10] = 7.07, p < 0.001 for cGMP-
IR), suggesting that glutamate produces both increases t
wthrough NO.
In agreement with similar previous studies (Rao and f
aCraig, 1997; Antonova et al., 2001), about 30% of syn-
aptophysin-IR puncta colocalized with GluR1-IR puncta v
b(Figures 4 and 5B). The remaining synaptophysin
puncta may colocalize with other types of receptors f
3(e.g., NMDA or GABA), may be part of transport pack-
ets (Ahmari et al., 2000), or may form prior to postsyn- t
iaptic puncta during synaptogenesis (Cohen-Cory,lect either incomplete maturity of the synapses or
imitations of the method for detecting colocalization.
onsistent with those possibilities, colocalization of sy-
aptophysin puncta with another vesicle-associated
rotein, synapsin I, which might be expected to be
early perfect, was only about 61%. Brief application
f glutamate that produced an increase in synaptophy-
in-IR puncta also produced an increase in the number
f GluR1-IR puncta (t[16] = 3.17, p < 0.01) and sites
here they colocalized and therefore might form func-
ional synapses (t = 3.27, p < 0.01). All three effects
ere reduced by Rp-8-Br-cGMPS (t[16] = 3.21, p < 0.01
or synaptophysin, t = 2.01, p < 0.05 one-tail for GluR1,
nd t = 2.08, p < 0.05 one-tail for colocalization). Con-
ersely, all three effects of glutamate were mimicked by
rief application of 8-Br-cGMP (t[34] = 3.69, p < 0.001
or synaptophysin, t = 2.32, p < 0.05 for GluR1, and t =
.20, p < 0.01 for colocalization). These results suggest
hat cGMP and cGK play roles in the postsynaptic
ncrease in GluR1 puncta as well as the presynaptic
Pre- and Postsynaptic Roles of NO, cGK, and RhoA
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an Endogenous Substrate, VASP,
during Potentiation
cGK type I is detectable by Western blot and PCR in
dissociated cultures of hippocampal neurons (Arancio
et al., 2001). It is present at a low level throughout the
cytoplasm but is concentrated in puncta, some of
which colocalize with synaptophysin (Figure 5). The
finding that cGK contributes to the increase in GluR1
puncta as well as synaptophysin puncta (Figure 4) sug-
gests that it might be localized in the postsynaptic as
well as presynaptic compartments. To attempt to ad-
dress that question, we divided the colocalized puncta
into ones that overlapped (at least in part) and ones
that were adjacent but did not overlap. In three dimen-
sions, overlapping puncta might be in either the same
or different compartments, but adjacent puncta are al-
most certainly in different compartments. Consistent
with that idea, only about 3% of colocalized synapto-
physin and synapsin I puncta were adjacent (which was
not significantly different from zero), whereas 30% to
45% of synaptophysin and GluR1 or NR1 puncta were
adjacent (Figure 5C). Similarly, about 40% of colocal-
ized synaptophysin and cGKI puncta were adjacent,
suggesting that at least some of the cGKI puncta are
postsynaptic.
We also examined immunoreactivity for VASP and
VASP phosphorylated at the cGK site (P-VASP). Our
P-VASP antibody can recognize P-Mena in vitro (Smo-
lenski et al., 2000), so it might have labeled for both
proteins. However, the puncta labeled with the P-VASP
antibody were a subset of puncta labeled with the
VASP antibody, which does not recognize Mena (Figure
6G), and we obtained more diffuse labeling with a Mena
antibody (data not shown), suggesting that the P-VASP
labeling is relatively specific. Like cGKI, VASP and
P-VASP are present at a low level throughout the cyto-
plasm but are concentrated in puncta, some of which
colocalize with the synaptic proteins synaptophysin,
synapsin I, or GluR1 (Figures 5 and 6). Approximately
42% of colocalized P-VASP puncta were adjacent to
puncta of the presynaptic protein synapsin I and ap-
proximately 47% were adjacent to puncta of the post-
synaptic protein GluR1 (Figure 5C), strongly suggesting
that P-VASP is localized in both the presynaptic and
postsynaptic compartments. The colocalization of
P-VASP with cGKI was roughly similar to that of synap-
tophysin and synapsin, suggesting that they are tightly
associated and that cGK phosphorylates VASP under
control conditions. The association of P-VASP and sGC
was somewhat less tight, perhaps because cGMP can
diffuse from sGC to cGK.
Brief application of glutamate that produced an in-
crease in the number of synaptophysin puncta had no
significant effect on the number of cGKI puncta (127% ±
15% of control, n = 6 + 6) or VASP puncta (105% ± 9%,
n = 6 + 6). However, glutamate did produce an increase
in P-VASP puncta (t = 2.79, p < 0.01) and sites where
synapsin and P-VASP colocalized (t = 2.38, p < 0.05)
(Figures 6A and 6B), suggesting that synaptic VASP is
phosphorylated at a cGK site during long-lasting po-
tentiation. Rp-8-Br-cGMPS alone produced a decrease
in the number of P-VASP puncta, particularly ones that
colocalized with synapsin puncta (t[25] = 2.94, p <0.01), supporting the idea that cGK phosphorylates
synaptic VASP under control conditions. Rp-8-Br-
cGMPS also blocked the glutamate-induced increases
in synapsin puncta (F[1,50] = 6.77, p < 0.05 for the glu-
tamate x Rp-8-Br-cGMPS interaction), P-VASP puncta
(F = 4.79, p < 0.05), and sites where synapsin and
P-VASP colocalized (F = 2.96, p < 0.05 one-tail). Con-
versely, brief application of 8-Br-cGMP that produced
an increase in GluR1 puncta also produced an increase
in P-VASP puncta (t = 3.63, p < 0.05), particularly ones
that colocalized with GluR1 puncta (t = 8.12, p < 0.01)
(Figures 6C and 6D). Rp-8-Br-cGMPS and 8-Br-cGMP
had generally similar effects on the overlapping and ad-
jacent P-VASP puncta (Figures 6E and 6F). These re-
sults suggest that cGK is activated and phosphorylates
VASP in both the presynaptic and postsynaptic com-
partments during potentiation. In addition, they raise
the possibility that phosphorylation of VASP may play
a role in the formation of new synaptic puncta.
Long-Lasting Potentiation Involves Both
Presynaptic and Postsynaptic Actin
The glutamate-induced increases in synaptophysin and
GluR1 puncta were also blocked by an inhibitor of actin
polymerization, cytochalasin D (Antonova et al., 2001),
and actin is thought to play an important role in LTP in
hippocampal slices and in vivo (Kim and Lisman, 1999;
Krucker et al., 2000; Fukazawa et al., 2003). Consistent
with those results, we found that cytochalasin D
blocked LTP in the CA1 region of hippocampal slices,
whereas an inhibitor of tubulin polymerization, nocoda-
zaole, had less of an effect (see Supplemental Results
1 in the supplemental material available with this article
online). Cytochalasin D (3 M for 1 hr) also greatly re-
duced the glutamate-induced potentiation of mEPSC
frequency in culture (F = 5.85, p < 0.05 compared to
glutamate alone; Supplemental Results 2) (Figure 7A).
By contrast, nocodazole (10 g/ml for 1 hr) produced a
smaller reduction, and the remaining potentiation was
still significant (F = 5.94, p < 0.05 compared to control).
Glutamate also produced a small but significant in-
crease in the amplitude of spontaneous mEPSCs in
these experiments (F = 10.89, p < 0.01 compared to
control) (Figure 7B), and cytochalasin D and nocoda-
zole both produced small reductions in this increase,
neither of which was significant. These results suggest
that polymerization of actin but not tubulin is required
for long-lasting potentiation of mEPSC frequency in
culture and that actin may also contribute to potentia-
tion of mEPSC amplitude.
Traditionally, an increase in mEPSC frequency is
thought to represent a presynaptic effect and an in-
crease in mEPSC amplitude is thought to represent a
postsynaptic effect, but both interpretations have been
challenged in recent years (Malinow and Malenka,
2002; Choi et al., 2003). Another approach to this ques-
tion is to inject inhibitors intracellularly into either the
presynaptic or postsynaptic neuron. Previous studies
in hippocampal slices have shown that injection of
phalloidin, which binds actin, into the postsynaptic
neuron reduces LTP, indicating that actin has a post-
synaptic role (Kim and Lisman, 1999), but those studies
could not address the question of whether actin also
Neuron
394Figure 6. cGK Phosphorylates Synaptic VASP during Potentiation
(A) Examples of synapsin I-IR, phosphoVASP-IR, and colocalization in dishes fixed 5 min after brief application of saline (control), glutamate,
or glutamate following pretreatment with Rp-8-Br-cGMPS. Scale bar, 5 m.
(B) Average results from experiments like the one shown in (A) (n = 18, 18, 9, and 9 dishes). The average control values per field were 87
(Syn), 33 (P-VASP), and 8 (colocalization).
(C) Examples of phosphoVASP-IR, GluR1-IR, and colocalization in dishes fixed 5 min after brief application of saline (control) or 8-Br-cGMP.
(D) Average results from experiments like the ones shown in (C) (n = 3 and 3). The average control values were 75 (P-VASP), 64 (GluR1), and
6 (colocalization).
(E and F) The colocalization data from (B) and (D) divided into cases where puncta of two different types either overlapped or were adjacent.
The average control values were 4.7 (overlap) and 3.1 (adjacent) in (E) and 2.5 and 3.2 in (F).
(G) Examples of phosphoVASP-IR, VASP-IR, and colocalization.has a presynaptic role. An advantage of the hippocam- g
Ppal cell culture system is that both sides of synapses
are accessible to substances injected into the cell bod- c
cies, allowing direct investigation of pre- as well as post-
synaptic mechanisms of plasticity (Popov and Poo, s
p1992; Arancio et al., 1995, 1996, 2001). We first con-
firmed that phalloidin-rhodamine can reach the pre- 1
and postsynaptic regions within 10 min (Figure S1) and
then investigated the effect of phalloidin on potentiation L
iof the evoked EPSC between two individual neurons.
Brief application of glutamate produced a rapid and a
Along-lasting increase in the amplitude of the EPSC
(F[1,40] = 7.39, p < 0.01 compared to test alone control t
g0–30 min after the glutamate) (Figures 7C and 7D). The
potentiation was not significantly affected by including (
ithe vehicle, DMSO, in either the postsynaptic pipette
(F = 6.25, p < 0.05 compared to control) or the presyn- t
naptic pipette (F = 7.66, p < 0.01 compared to control).
By contrast, the potentiation was greatly reduced by s
aincluding phalloidin (100 M) in either the postsynaptic
pipette (F = 4.84, p < 0.05 compared to postsynaptic (
rDMSO) or the presynaptic pipette (F = 4.29, p < 0.05
compared to presynaptic DMSO). Neither pre- nor post- p
asynaptic phalloidin alone had a significant effect on theradual rundown of the EPSC, compared to control.
re- or postsynaptic phalloidin also did not have signifi-
ant effects on the amplitude of the baseline EPSC,
ompared either to no injection or to DMSO. These re-
ults suggest that the potentiation in culture involves
ostsynaptic actin, like LTP in slices (Kim and Lisman,
999), and show that it also involves presynaptic actin.
ong-Lasting Potentiation and the Increases
n Puncta Involve Both Presynaptic
nd Postsynaptic RhoA
general inhibitor of Rho GTPases, Clostridium difficile
oxin B (5 ng/ml for 2 hr), significantly reduced the
lutamate-induced potentiation of mEPSC frequency
F[1,77] = 5.05, p < 0.05 for the glutamate × toxin B
nteraction) (Figure 8A). Toxin B also tended to reduce
he increase in mEPSC amplitude, but that effect was
ot significant (Figure 8B). Toxin B by itself did not have
ignificant effects on the baseline mEPSC frequency or
mplitude. An inhibitor of RhoA-dependent kinase
ROCK), Y27632 (5–10 M for 2 hr) also significantly
educed the potentiation of mEPSC frequency (F = 5.19,
< 0.05 for the glutamate × Y27632 interaction) as well
s amplitude (F = 4.72, p < 0.05 for the interaction).
Pre- and Postsynaptic Roles of NO, cGK, and RhoA
395Figure 7. Long-Lasting Potentiation Involves Both Presynaptic and Postsynaptic Actin
(A) The average change in mEPSC frequency following brief application of saline (control), glutamate, glutamate following pretreatment with
cytochalasin D, or glutamate following pretreatment with nocodazole. There was a significant overall difference between the four groups in a
two-way ANOVA with one repeated measure (F[3,47] = 6.58, p < 0.001). The average baseline values (in min−1) were 537 (control, n = 12), 589
(glutamate, n = 20), 257 (glutamate + cytochalasin D, n = 10), and 524 (glutamate + nocodazole, n = 9).
(B) The average change in mEPSC amplitude 0–30 min after the glutamate application in the same experiments as (A). There was a significant
overall difference between the four groups (F = 3.77, p < 0.05). The average baseline vaues (in pA) were −14, −15, −16, and −11, not
significantly different by a one-way ANOVA.
(C) Examples of evoked EPSCs produced in a postsynaptic neuron by step depolarization that elicited an inward current in the presynaptic
neuron before (Pre) and 5 and 25 min after brief application of glutamate.
(D) The average changes in EPSC amplitude following brief application of saline (control) or glutamate. In some of the experiments, either
phalloidin, which binds actin, or vehicle (DMSO) was included in either the presynaptic or postsynaptic pipette. There was a significant overall
difference between the eight groups (F[7,40] = 2.92, p < 0.05). Each point represents the average of 30 successive trials, normalized to the
average value during the 10 min before glutamate application (baseline) in each experiment. The average baseline values (in pA) were −404
(control, n = 6), −116 (glutamate, n = 8), −122 (glutamate + postsynaptic DMSO, n = 5), −48 (glutamate + presynaptic DMSO, n = 7), −303
(glutamate + postsynaptic phalloidin, n = 6), −359 (glutamate + presynaptic phalloidin, n = 6), −66 (postsynaptic phalloidin alone, n = 5), and
−70 (presynaptic phalloidin alone, n = 5).These reductions were in part due to a tendency for
Y27632 to increase the control mEPSC frequency and
amplitude, but neither increase was quite significant
(p = 0.14 and 0.08). These results suggest that Rho
GTPases including RhoA and ROCK may contribute to
long-lasting potentiation of both mEPSC frequency
and amplitude.
Tetanic stimulation of the presynaptic neuron paired
with postsynaptic depolarization and brief perfusion
with nominally 0 Mg2+ saline also produced rapid and
long-lasting potentiation of the evoked EPSC (Figure
S2). The potentiation was blocked by D-APV (50 M for
20 min; F = 15.41, p < 0.001) or cytochalasin D (3 M
for 1 hr; F = 9.66, p < 0.01), whereas cytochalasin D
alone had no significant effect, suggesting that potenti-
ation by tetanic stimulation in culture requires NMDA
receptor activation and actin polymerization, like po-
tentiation with other protocols. To examine the role ofRhoA and test whether it acts presynaptically, postsyn-
aptically, or both during the potentiation, we used re-
combinant adenovirus to express either a dominant-
negative form of RhoA and GFP, a constitutively active
form of RhoA and GFP, or GFP alone (control) in some
of the neurons in the cultures. We then tested potentia-
tion of the EPSC between two individual neurons, one
of which exhibited GFP fluorescence. Tetanic stimula-
tion still produced potentiation when GFP alone was
expressed in the postsynaptic neuron (F[1,70] = 14.39,
p < 0.001 compared to test-alone control) or the pre-
synaptic neuron (F = 10.20, p < 0.01) (Figures 8C and
8D). However, the potentiation was blocked when do-
minant-negative RhoA and GFP were expressed in
either the postsynaptic neuron (F = 4.35, p < 0.05 for
the tetanus × dominant-negative RhoA interaction) or
the presynaptic neuron (F = 3.59, p < 0.05 one-tail). Nei-
ther pre- nor postsynaptic expression had significant
Neuron
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Both Presynaptic and Postsynaptic RhoA
(A) The average change in mEPSC frequency
following brief application of saline (control),
glutamate, pretreatment with the Rho
GTPase inhibitor toxin B, glutamate follow-
ing pretreatment with toxin B, pretreatment
with the ROCK inhibitor Y27632, or gluta-
mate following pretreatment with Y27632.
There were significant overall effects of glu-
tamate (F[1,77] = 17.14, p < 0.001), inhibitor
(F[2,77] = 4.50, p < 0.05), and their interac-
tion (F[2,77] = 3.86, p < 0.05) in a three-way
ANOVA. The average baseline values (in
min−1) were 85 (control, n = 15), 43 (gluta-
mate, n = 27), 68 (toxin B, n = 7), 100 (gluta-
mate + toxin B, n = 8), 33 (Y27632, n = 9),
and 24 (glutamate + Y27632, n = 17), not sig-
nificantly different.
(B) The average change in mEPSC amplitude
0–30 min after the glutamate application in
the same experiments as (A). The average
baseline values (in pA) were −24, −23, −19,
−22, -28, and −29, not significantly different.
(C) The average changes in EPSC amplitude
following either test-alone control stimula-
tion or tetanic stimulation of the presynaptic
neuron paired with postsynaptic depolarization and perfusion with 0 Mg2+ saline (Tet) following expression of GFP alone, dominant-negative
RhoA (RhoA−) and GFP, or constitutively active RhoA (RhoA+) and GFP in the postsynaptic neuron.
(D) The average changes in EPSC amplitude in similar experiments following presynaptic expression. There were significant overall effects of
tetanic stimulation (F[1, 70] = 7.74, p < 0.01), expressed protein (F[2,70] = 3.61, p < 0.05), and their interaction (F[2,70] = 5.91, p < 0.01). The
average baseline values (in pA) were −96 (GFP post con, n = 10), −23 (GFP post tet, n = 7), −24 (RhoA− post con, n = 4), −37 (RhoA− post
tet, n = 6), −110 (RhoA+ post con, n = 11), −94 (RhoA+ post tet, n = 10), −22 (GFP pre con, n = 9), −17 (GFP pre tet, n = 7), −37 (RhoA− pre
con, n = 4), −17 (RhoA− pre tet, n = 6), −35 (RhoA+ pre con, n = 3), and −13 (RhoA+ pre tet, n = 5). There was a significant overall effect on
baseline values of presynaptic versus postsynaptic expression (F[1,76] = 6.09, p < 0.05) but no significant difference between GFP, RhoA−,
and RhoA+.effects on the test-alone control. These results suggest 0
pthat both presynaptic and postsynaptic RhoA are re-
quired for the potentiation. p
uThe potentiation was also blocked by expression of
constitutively active RhoA and GFP in either the post- n
asynaptic neuron (F = 3.17, p < 0.05 one-tail) or the pre-
synaptic neuron (F = 5.33, p < 0.05), with no significant (
Geffects on the test-alone control. Constitutively active
RhoA might act by producing potentiation and occlud- b
ping the potentiation by tetanic stimulation. Consistent
with that idea, there was a trend for the baseline EPSC p
tamplitude to be larger with postsynaptic expression of
constitutively active RhoA and GFP (−103 ± 26 pA) and t
lsmaller with dominant-negative RhoA and GFP (−32 ±
10 pA) compared to GFP alone (−66 ± 23 pA). However, i
sthere was no difference in baseline EPSC amplitude
when these different proteins were expressed presyn- a
paptically, suggesting that presynaptic expression of
constitutively active RhoA blocks potentiation by some d
fadditional mechanism. Expression of constitutively
active RhoA has been shown to produce a simplifica-
tion of dendritic and axonal structure that might in- R
Dterfere with potentiation (Nakayama et al., 2000; Bito et
al., 2000), but we did not observe any consistent differ- T
iences in the gross morphology or dendritic branching
of the neurons under our conditions (Figure S3). s
GWe next examined whether Rho GTPases including
RhoA were involved in structural changes on a smaller s
pscale. Toxin B blocked the glutamate-induced in-
creases in synaptophysin puncta (F[1,54] = 8.84, p < w.01 for the glutamate × toxin B interaction), GluR1
uncta (F = 4.15, p < 0.05), and sites where synapto-
hysin and GluR1 colocalized (F = 5.03, p < 0.05) (Fig-
re 9). Toxin B also produced a decrease in the baseline
umber of synaptophysin puncta (t[28] = 2.34, p < 0.05)
nd sites where synaptophysin and GluR1 colocalized
t = 1.93, p < 0.05 one-tail), with no effect on baseline
luR1 puncta. Likewise, Y27632 (10–100 M for 2 hr)
locked the glutamate-induced increases in synapto-
hysin puncta (F[1,44] = 15.55, p < 0.001), GluR1
uncta (F = 3.45, p < 0.05 one-tail), and sites where
hey colocalized (F = 18.86, p < 0.001). However, unlike
oxin B, Y27632 tended to produce increases in base-
ine synaptophysin puncta and colocalization, similar to
ts effects on baseline mEPSCs (Figure 8). These results
uggest that Rho GTPases including RhoA and ROCK
re involved in the increases in both presynaptic and
ostsynaptic puncta and sites where they colocalize
uring potentiation and that Rho GTPases may play dif-
erent roles under baseline conditions.
ho GTPases Act Upstream but Not
ownstream of cGMP
oxin B also tended to reduce the 8-Br-cGMP-induced
ncreases in synaptophysin puncta and sites where
ynaptophysin and GluR1 colocalized with no effect on
luR1 puncta, but in this case the reductions were not
ignificantly greater than the reductions that toxin B
roduced in baseline levels of puncta (that is, there
ere not significant 8-Br-cGMP × toxin B interactions)
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and GluR1 Puncta during Potentiation In-
volve Rho GTPases Including RhoA
(A) Examples of synaptophysin immunofluo-
rescence, GluR1 immunofluorescence, and
colocalization in dishes fixed 5 min after
brief application of saline (control), gluta-
mate, glutamate following pretreatment with
toxin B, or glutamate following pretreatment
with Y27632. Scale bar, 5 m.
(B) Average results with toxin B from experi-
ments like the ones shown in (A) (n = 15, 6,
15, and 6). The average control number of
puncta per field were 46 (syp), 62 (GluR1),
and 18 (colocalization).
(C) Average results with Y27632 (n = 12 in
each group). The average control number of
puncta per field were 20 (syp), 42 (GluR1),
and 6 (colocalization).(Figures 10A and 10B). Thus, unlike the glutamate-
induced increases in puncta (Figure 9), Rho GTPases
do not appear to play an important role in the 8-Br-
cGMP-induced increases in synaptophysin and GluR1
puncta.
Toxin B also did not block the ability of 8-pCPT-
cGMP to “rescue” glutamate-induced potentiation in
the presence of Nϖ-nitro-L-arginine (F = 8.12, p < 0.01
compared to control) (Figure 1C), again suggesting that
Rho GTPases do not act downstream of cGMP. Another
way of interpreting this result is that 8-pCPT-cGMP res-
cued potentiation in the presence of toxin B (plus Nϖ-
nitro-L-arginine). Consistent with that idea, toxin B
blocked the glutamate-induced increase in cGMP-IR
intensity in the synaptophysin puncta (F[1,52] = 5.18,
p < 0.05 for the glutamate × toxin B interaction) (Figures
10C and 10D). These results suggest that Rho GTPases
act in part upstream (rather than downstream) of the
increase in cGMP during potentiation.
Rho GTPases might be involved in the ongoing main-
tenance of synaptic protein complexes upstream of
cGMP. Soluble guanylyl cyclase (sGC) is generally
thought to be cytoplasmic, but it can be localized to al., 1994; Dinerman et al., 1994), but more recent evi-
Figure 10. Rho GTPases Act Upstream but
Not Downstream of cGMP
(A) Examples of synaptophysin-IR, GluR1-IR,
and colocalization in dishes fixed 5 min after
brief application of 8-Br-cGMP or 8-Br-cGMP
following pretreatment with toxin B. Scale
bar, 5 m.
(B) Average results from experiments like the
ones shown in (A) (n = 15, 9, 15, and 9
dishes). The average control values per field
in these experiments were 46 (syp), 62
(GluR1), and 18 (colocalization).
(C) Examples of synaptophysin-IR and
cGMP-IR in dishes fixed 5 min after brief ap-
plication of glutamate or glutamate following
pretreatment with toxin B. Scale bar, 5 M.
(D) Average results from experiments like the
ones shown in (C) (n = 9, 9, 7, and 9). The
average control number of puncta was 45.presynaptic active zones (Burette et al., 2002), perhaps
by interacting with the PDZ domain of scaffolding pro-
teins (Russwurmm et al., 2001). Consistent with that
idea, we observed a low level of sGC immunoreactivity
throughout the cytoplasm with higher levels in puncta,
some of which colocalized with synaptophysin puncta
(Figure 5). Toxin B produced a decrease in the number
of sites where synaptophysin and sGC colocalized
(41% ± 9% of control, t = 3.49, p < 0.01), which was
approximately equal for overlapping (44% ± 11%) and
adjacent (38% ± 8%) puncta. Toxin B also produced a
decrease in the intensity of sGC-IR in the synaptophy-
sin puncta (t = 3.53, p < 0.01) (Figures 11A and 11B).
These results suggest that Rho GTPases play a consti-
tutive role in maintaining the synaptic localization of
sGC.
The neuronal isoform of NOS (nNOS) is also cyto-
plasmic, but associates with the postsynaptic scaffold-
ing protein PSD95 by PDZ domain interactions (Bren-
man et al., 1996). Previous evidence suggested that
both nNOS and the endothelial isoform (eNOS) are lo-
cated in hippocampal pyramidal neurons (Wendland et
Neuron
398Figure 11. Rho GTPases Play a Role in Main-
taining the Synaptic Localization of Soluble
Guanylyl Cyclase but Not nNOS
(A) Examples of synaptophysin-IR and sGC-
IR in a control dish and a dish fixed after pre-
treatment with toxin B. Scale bar, 5 m.
(B) Average results from experiments like the
ones shown in (A) (n = 12 and 13 dishes). The
average control number of puncta per field
was 36.
(C) Examples of PSD95-IR and nNOS-IR in a
control dish and a dish fixed after pretreat-
ment with toxin B.
(D) Average results from experiments like the
ones shown in (C) (n = 8 and 8). The average
control number of puncta was 27.dence suggests that only nNOS is neuronal (Blackshaw N
iet al., 2003). We observed a low level of nNOS immuno-
reactivity throughout the cytoplasm of the neurons, e
pwith higher levels in puncta, some of which colocalized
with PSD95 puncta (Figures 11C and 11D). Unlike the m
tresults with synaptophysin and sGC, toxin B had no
significant effect on the number or size of PSD95 S
Wpuncta and produced an increase in the intensity of
nNOS-IR in the PSD95 puncta (t[14] = 2.30, p < 0.05). c
pThis result was the reverse of the one predicted, but it
might also represent some disruption of normal nNOS o
slocalization, or it might represent attempted compensa-
tion for the decrease in sGC. o
a
pDiscussion
a
bRole of the NO-cGMP-cGK Pathway
bin the Potentiation and Increase in Puncta
oOur immunocytochemical results suggest that nNOS,
msGC, cGMP, cGKI, and the cGK substrate VASP are all
ppresent in hippocampal neurons, in agreement with
iprevious reports (Wendland et al., 1994; Burette et al.,
r2002; DeVente et al., 1988; Matsuoka et al., 1992; Verma
et al., 1993; Kingston et al., 1996; Kleppisch et al., 1999;
Arancio et al., 2001). Furthermore, we found that they F
Tall colocalized with the synaptic proteins synaptophy-
sin, synapsin I, or PSD95, consistent with the idea that i
ithey have synaptic functions. We also found (1) that
inhibitors of NOS or cGK block both the potentiation 2
Mand the increase in puncta of synaptic proteins, (2) that
exogenous NO or cGMP analogs produce increases in p
cpuncta, and (3) that cGMP is elevated and cGK is acti-
vated and phosphorylates synaptic VASP during poten- t
btiation. These results support a role of the NO-cGMP-
cGK pathway in the potentiation and increase in puncta. c
tA somewhat surprising result of this study is that
cGMP and cGK are involved in the increases in post- n
csynaptic GluR1 puncta as well as presynaptic synapto-
physin puncta. NO, cGMP, and cGK are known to act t
cdirectly in the presynaptic neurons during long-lasting
potentiation (Arancio et al., 1995, 1996, 2001), and NO t
Rand cGMP also contribute to activity-dependent regu-
lation of synaptic vesicle cycling (Micheva et al., 2003; Ninan and Arancio, 2004), supporting a functional role
n presynaptic plasticity. However, those results don’t
xclude an additional postsynaptic function, and some
revious studies have suggested that cGMP and cGK
ay play a role in the postsynaptic as well as presynap-
ic neurons during potentiation (Arancio et al., 2001;
on et al., 1998; Lu et al., 1999; Lu and Hawkins, 2002).
ith light microscopic methods, one cannot say with
ertainty whether a given type of molecule is located
resynaptically or postsynaptically, but our analysis of
verlapping versus adjacent colocalization of puncta
uggests that sGC, cGKI, and VASP can each be found
n both sides of the synapse and that cGK is activated
nd phosphorylates VASP both presynaptically and
ostsynaptically during potentiation. A similar analysis
s well as electron microscopic evidence from adult
rain sections also suggests that sGC is present on
oth sides of the synapse, although with relatively more
n the presynaptic side (Burette et al., 2002). Thus, NO
ay activate sGC and cGK simultaneously in both the
resynaptic and postsynaptic neurons, perhaps engag-
ng similar mechanisms and thus producing coordinate
egulation of the two sides of the synapse (Figure 12A).
unctional Role of NO Signaling
he NO-cGMP-cGK pathway is thought to be involved
n a variety of learning-related forms of synaptic plastic-
ty (Hawkins, 1996; Feil et al., 2003; Stanton et al.,
003), including hippocampal LTP (Hawkins et al., 1998;
ontfort et al., 2002; Bon and Garthwaite, 2003; Klep-
isch et al., 2003). However, the roles of NO, cGMP, and
GK in LTP have been controversial, in part because
hey appear to be involved under some circumstances
ut not others (reviewed in Hawkins et al., 1998). NO,
GMP, and cGK make particularly large contributions
o long-lasting potentiation in cultured hippocampal
eurons (Arancio et al., 1995, 1996, 2001), perhaps be-
ause the neurons are not fully mature. Consistent with
hat idea, NO, cGMP, and cGK have also been impli-
ated in late-stage developmental processes or synap-
ogenesis (Hindley et al., 1997; Van Wagenen and
ehder, 1999; Leamy et al., 2001; Schmidt et al., 2002;
ishiyama et al., 2003). Moreover, long-lasting potentia-
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399Figure 12. Proposed Roles of NO, cGMP, cGK, VASP, and Rho
GTPases in the Increases in Synaptophysin and GluR1 Puncta at
the Onset of Long-Lasting Potentiation
(A) Molecular pathways. Ca2+ influx through postsynaptic NMDA
receptor channels stimulates production of NO, leading to activa-
tion of both presynaptic and postsynaptic soluble guanylyl cyclase
(sGC) and cGK and phosphorylation of VASP, which may in turn
contribute to aggregation of synaptophysin and GluR1 by regulat-
ing the actin cytoskeleton. RhoA and Rho kinase (ROCK) appear to
act in parallel with this pathway, and Rho GTPases also contribute
to maintaining the synaptic localization of sGC.
(B) Possible roles of these molecular pathways in both strengthen-
ing of existing synapses (top) and the formation of new synapses
(bottom). See the Discussion for details.tion resembles synaptic development (Sanes and Licht-
man, 1999; Cohen-Cory, 2002) in that it appears to in-
volve the formation of new clusters of both pre- and
postsynaptic proteins in a coordinated fashion (Anto-
nova et al., 2001).
Because the late, protein synthesis-dependent phase
of long-term potentiation is also thought to involve the
growth of new synapses (Luscher et al., 2000; Bozdagi
et al., 2000), the rapid formation of new clusters or
puncta may represent a very early step in that process.
Both the pre- and postsynaptic puncta form in less than
10 min, and the presynaptic puncta can form in as little
as 1 min (Figure 2). The early stages of long-term poten-
tiation are also accompanied by the enlargement of ex-isting postsynaptic spines (Matsuzaki et al., 2004) and
the formation of new presynaptic filopodia, which begin
to appear around 10 min and involve NO (Nikonenko et
al., 2003). These results suggest a sequence in which
postsynaptic production of NO first triggers formation
of presynaptic puncta, which could then play some role
in the formation of presynaptic filopodia. Similarly, the
new presynaptic filopodia could play a role in the for-
mation of new postsynaptic spines and morphologi-
cally mature synapses, which occurs around 30–60 min
(Engert and Bonhoeffer, 1999; Maletic-Savatic et al.,
1999; Toni et al., 1999; Nikonenko et al., 2003). Any of
these early structural changes could in turn be the
“tag” that must be stabilized by protein synthesis for
more enduring plasticity (Frey and Morris, 1997).
The growth of new synapses is thought to involve
a variety of anterograde and retrograde messengers,
including adhesion molecules, growth factors, and
other secreted factors, which may serve different func-
tional roles and act cooperatively (Scheiffele, 2003). Our
results suggest that the NO-cGMP-cGK pathway may
be added to this list. The idea that long-lasting plastic-
ity involves growth also suggests a possible novel role
for a diffusible messenger such as NO, which is to sig-
nal the de novo formation of synapses at new locations
in response to activation of NMDA receptors at existing
synapses (Figure 12B). Antonova et al. (2001) observed
a rapid increase in presynaptic puncta that colocalized
with GluR1, NR1, or PSD95 puncta and therefore might
be triggered by very local retrograde signaling, for ex-
ample through adhesion molecules. However, they also
observed an increase in presynaptic puncta that did not
colocalize with any of these postsynaptic puncta but
nevertheless also required NMDA receptor activation,
suggesting the involvement of a messenger that dif-
fuses from the NMDA receptors to the location of the
new puncta. We have found that inhibitors of the NO-
cGMP-cGK pathway block the increases in synapto-
physin puncta that are either colocalized or not colo-
calized with postsynaptic puncta, suggesting that NO
can act as such a messenger both very locally and at
some distance. Furthermore, NMDA receptors and the
NO-cGMP-cGK pathway also plays roles in the forma-
tion of new GluR1 puncta that are either colocalized or
not colocalized with synaptophysin puncta and there-
fore may form in new locations as well. Such insertion
of receptors at de novo synapses in addition to existing
synapses might reconcile the “silent synapse” hypothe-
sis (insertion of AMPA receptors at synapses previously
lacking them [Malinow and Malenka, 2002]) with some
of the data (including our own) suggesting that potenti-
ation also involves presynaptic changes. If, for exam-
ple, the new synapses had new AMPA receptors and
no new NMDA receptors, the results at the level of
whole-cell recording would be indistinguishable from
insertion of AMPA receptors at old “silent” synapses
and yet involve a presynaptic component (new func-
tional release sites) as well. Although this possibility is
the reverse of what is often assumed, it is consistent
with some of the data on synaptogenesis (Friedman et
al., 2000) and suggests additional variations on mecha-
nisms of synaptic plasticity that have not generally
been considered.
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400Roles of Actin, VASP, and Rho GTPases, p
and Relationships between the Signaling Pathways (
Actin is thought to play an important role in the struc- t
tural organization of presynaptic as well as postsynap- a
tic proteins and the modification of that organization p
during several forms of plasticity (Luo, 2002). Actin acts a
at least in part in the postsynaptic cells during LTP (Kim p
and Lisman, 1999), but it was not previously known a
whether actin plays a presynaptic role as well. In addi- l
tion, although VASP and Rho GTPases are involved in e
late-stage developmental processes (Korey and Van 2
Vactor, 2000; Luo, 2002; Sin et al., 2002; Lebrand et al., t
2004), relatively little was known about their possible a
roles in synaptic plasticity. Ena/VASP proteins have w
been implicated in targeting of profilin to postsynaptic l
spines and stabilization of actin following glutamate s
application in hippocampal cultures (Ackermann and A
Matus, 2003). RhoA and Rho kinase (ROCK) contribute R
to amygdala-dependent learning (Lamprecht et al., t
2002), and another Rho GTPase, Cdc42, plays an im- u
portant role in both the functional and structural g
changes during long-term facilitation in Aplysia (H.U., C
personal communication). In addition, late-phase LTP
Ein hippocampus is blocked by an inhibitor of cofilin,
suggesting that late LTP might involve Rho GTPases as
Awell (Fukazawa et al., 2003).
cWe have found that actin and Rho GTPases including t
RhoA are involved in even the early phase of long-last- p
ing potentiation and that they act on both sides of the i
synapses. Moreover, blocking actin or RhoA in either
Ethe presynaptic or postsynaptic neuron blocked poten-
Etiation completely (Figures 7 and 8), suggesting that the
cpresynaptic and postsynaptic mechanisms are not sim-
s
ply additive, but rather interact in some way. Blocking t
actin or RhoA also blocked the increases in puncta of (
presynaptic and postsynaptic proteins and sites where v
tthey colocalize at the onset of potentiation (Antonova
tet al., 2001, and Figure 9). These results are consistent
ewith the idea that potentiation involves the rapid struc-
tural modification of existing synapses or formation of S
new synapses, which would require coordinated T
changes on both sides of the synapse. In addition, we c
found that synaptic VASP is phosphorylated by cGK p
(during the potentiation, suggesting that VASP may be
einvolved as well. In other systems, cGK also phos-
phorylates RhoA (Sauzeau et al., 2000; Gudi et al.,
12002; Zhuang et al., 2004), which can act cooperatively 1
with VASP (Grosse et al., 2003). However, our results l
suggest that cGK acts in parallel and downstream (
(rather than upstream) of Rho GTPases, which control d
lthe localization of sGC and thus regulate cGMP levels
Tduring long-lasting potentiation. This pathway may ex-
oplain part of the contribution of Rho GTPases to the
s
increases in EPSCs and puncta during the potentiation. w
How these pathways relate to other presynaptic and 1
postsynaptic molecules involved in potentiation (Mali- (
now and Malenka, 2002; Ninan and Arancio, 2004) re-
Amains to be explored. One idea is suggested by com-
Rparing our results on potentiation and the increases in
Rpuncta of synaptic proteins during the potentiation. In
m
general, there was very good agreement between the e
time courses and pharmacology of the two effects, (
suggesting that they may be mechanistically related. R
RHowever, one exception was that cGMP analogs aloneroduced an increase in immunofluorescent puncta
Figures 4 and 10) but did not produce potentiation of
he frequency of mEPSCs (Figure 1). Similarly, cGMP
nalogs alone produced an increase in FM1-43-labeled
uncta without producing potentiation of EPSCs (Ninan
nd Arancio, 2004). In most studies, the analogs have
roduced potentiation only when they were paired with
ctivity, often in a “rescue” paradigm (Figure 1 and Ha-
ey et al., 1992; Zhuo et al., 1994; Son et al., 1998; Lu
t al., 1999; Lu and Hawkins, 2002; Ninan and Arancio,
004), suggesting that paired activity may be necessary
o make the puncta functional physiologically. An
ttractive candidate for this activity-dependent step
ould be CamKII, which is thought to be involved in
ong-lasting potentiation both presynaptically and post-
ynaptically (Malinow and Malenka, 2002; Ninan and
rancio, 2004), like the NO-cGMP-cGK pathway and
hoA. Thus, an interesting possibility is that potentia-
ion may involve basically the same sequence of molec-
lar events (NO-cGMP-cGK- and RhoA-dependent ag-
regation of proteins that are then made functional by
amKII) on both sides of the synapses.
xperimental Procedures
ll experiments were performed on dissociated cultures of hippo-
ampal neurons from one-day-old Spague Dawley rats. The cul-
ures were prepared and plated on glass coverslips as described
reviously (O’Dell et al., 1991) and were used 10–20 days after plat-
ng (Supplemental Procedures 1).
lectrophysiology
lectrophysiological methods were as described previously (Aran-
io et al., 1995). Cultures from the same batch were randomly as-
igned to the different experimental groups. Data were normalized
o the baseline values and analyzed using one-way or two-way
group and time) ANOVAs followed by planned comparisons of indi-
idual groups. mEPSC frequencies were log transformed to make
hem more normally distributed for analysis with parametric statis-
ics, and the graphs show the geometric means. p < 0.05 is consid-
red significant (Supplemental Procedures 2).
ynaptophysin-GFP Imaging and Immunocytochemistry
he methods for synaptophysin-GFP imaging and immunocyto-
hemistry were as described previously (Antonova et al., 2001). The
rimary antibodies were mouse monoclonal anti-synaptophysin
Boehringer Mannheim Biochem; 5 g/ml), sheep anti-cGMP (Tanaka
t al., 1997; diluted 1:100), rabbit polyclonal anti-GluR1 (Chemicon; 20
g/ml), affinity-purified rabbit anti-cGKI (Markert et al., 1995; diluted
:200), rabbit polyclonal anti-VASP (prepared by M. Reinhard; diluted
:200), mouse monoclonal anti-phospho (serine 239)-VASP (Smo-
enski et al., 1998; 3 g/ml), affinity-purified rabbit anti-synapsin I
Molecular Probes; diluted 1:200), rabbit polyclonal anti-sGC (Alexis;
iluted 1:200), mouse monoclonal anti-PSD95 (Affinity Bioreagent; di-
uted 1:100), or rabbit polyclonal anti-nNOS (Chemicon; 5–10 g/ml).
o check the specificity of the immunofluorescence, we either
mitted the primary antibody or used preimmune serum. The inten-
ity of cGMP, sGC, or nNOS immunofluorescence was measured
ithin the boundaries of synaptophysin or PSD95 puncta (Figures
0 and 11) or in a representative region of the somatic cytoplasm
Figure 3) using fixed laser intensity and gain settings.
denovirus-Mediated Expression of Recombinant
hoA and GFP
hoA was cloned from a mouse hippocampal cDNA library, and
utations were introduced by a PCR-based method to obtain
ither dominant-negative (RhoAT19N) or constitutively active
RhoAG14V) forms. Recombinant adenoviruses expressing either
hoAT19N and EGFP under control of the same promoter,
hoAG14V and EGFP, or EGFP alone were constructed using an
Pre- and Postsynaptic Roles of NO, cGK, and RhoA
401AdEasy system (He et al., 1998). Rat hippocampal cultures were
infected at 1–10 MOI 10–14 days after plating and were incubated
for 2–3 more days to allow expression of recombinant protein,
which was confirmed by Western blot analysis (Antonova et al.,
2001).
Supplemental Data
Supplemental material including figures, results, and procedures
are available online at http://www.neuron.org/cgi/content/full/45/3/
389/DC1/.
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